Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000035

Chief Medical Officer sold 7,000 shares at an average $66.12 ($462,830)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-15 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 36,877 D
2026-04-15 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 40,377 D
2026-04-15 Sale : show line 3 in the form 10b5-1 −4,227 $65.73 $277,837 36,150 D
2026-04-15 Sale : show line 4 in the form 10b5-1 −2,273 $66.56 $151,301 33,877 D
2026-04-15 Sale : show line 5 in the form 10b5-1 −500 $67.38 $33,692 33,377 D
Open-market sales · 7,000 sh · avg $66.12 · $462,830

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-15 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 211,063 D
2026-04-15 Exercise or conversion : show line 7 in the form 10b5-1 Employee Warrant (right to buy) −3,500 182,492 D
Loading xslF345X06/form4.xml…